logo
  

Stock Alert: Synovus Financial Rises On Better-than-expected Q3 Results

Shares of commercial and retail banking, investment, and mortgage services provider Synovus Financial Corp. (SNV) are rising more than 4% Tuesday morning after reporting better-than-expected third-quarter results.

Third-quarter earnings on an adjusted basis were $0.89 per share compared with $0.97 per share last year. Analysts polled by Thomson Reuters were expecting earnings of $0.52 for the quarter.

Total revenues were $493.65 million in the third quarter compared with $494.21 million in the same quarter a year ago. The consensus estimate was for $469.67 million.

"The third quarter reflected strong operating performance, highlighted by growth in core transaction deposits of $1.6 billion and adjusted fee income growth of $20 million, as well as disciplined expense management, all contributing to improved profitability," said Kessel D. Stelling, Synovus Chairman and CEO.

Synovus stock is currently trading at $25. It has been trading in the range of $10.91- $40.32 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
The U.S. Consumer Product Safety Commission or CPSC has announced recalls including earmuffs, racer car toys, log splitters and cylinder kits, hampshire cribs, and air rifles, citing various reasons. 3M Co. has recalled Peltor X4 Series Earmuffs citing risk of overexposure to loud noise and sound, while Santa Monica, California -based JAKKS Pacific Inc. has called back children's Mario Kart... Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq.

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
RELATED NEWS
Follow RTT